Tag: Wholesalers
Five-star fund manager bets on cheap AI, beer and China plays
We’ve got big tech earnings on the way from Microsoft and Alphabet, as a Fed meeting looms. What are big money managers worried about? “The [Read more about this post…]
The busiest and most crucial week for fourth-quarter earnings is here.
The heaviest stretch of the fourth-quarter earnings storm hits this week, with 106 companies set to report results. But results from only five — all [Read more about this post…]
Sunoco to acquire NuStar in $7.3 billion deal including debt
Sunoco LP and pipeline operator NuStar Energy LP said Monday they have agreed to combine in an all-stock deal valued at about $7.3 billion, including [Read more about this post…]
This stock fund manager outperforms with ‘fixer-uppers’
Small-cap stocks can help investors diversify from the S&P 500, which is heavily weighted to the largest U.S. tech players. Investors may imagine small-caps as [Read more about this post…]
Dow rises as yields fall, while tech buoys S&P 500, Nasdaq
Stocks traded higher Monday afternoon as tech stocks were lifted by a pullback in Treasury yields. What’s happening The Dow DJIA rose 120 points, or [Read more about this post…]
Trying to get rid of your credit-card debt in 2024? Here’s your action plan. by StuffsEarth
A New Year’s pledge to pay down debt is common — but the resolution has new urgency for credit-card bills in 2024. Let’s start with [Read more about this post…]
Here are the 20 worst-performing stocks among the S&P 500 in 2023
(Updated with Friday’s closing prices.) The U.S. stock market staged a remarkable rally in 2023, but 178 stocks in the S&P 500 were still down [Read more about this post…]
Nvidia tops list of Wall Street’s 20 favorite stocks for 2024
Investors have driving quite a bounceback for stocks during 2023, and the trend for gains that started late in October has been gaining steam. Below [Read more about this post…]
Five obesity-drug trends to watch in 2024
The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the [Read more about this post…]